Detalles de la búsqueda
1.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
N Engl J Med;
388(25): 2338-2348, 2023 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342922
2.
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Haematologica;
2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572562
3.
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation.
Biol Blood Marrow Transplant;
26(9): 1670-1678, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562858
4.
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
26(10): 1876-1885, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653622
5.
Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
J Natl Compr Canc Netw;
18(2): 169-175, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32023530
6.
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
25(8): 1689-1694, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30965140
7.
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation.
Biol Blood Marrow Transplant;
25(8): 1682-1688, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30710686
8.
Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting.
Biol Blood Marrow Transplant;
25(4): 827-833, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572109
9.
Impact of a health information technology tool addressing information needs of caregivers of adult and pediatric hematopoietic stem cell transplantation patients.
Support Care Cancer;
27(6): 2103-2112, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30232587
10.
Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Haematologica;
108(1): 250-256, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36106394
11.
BMT Roadmap: A User-Centered Design Health Information Technology Tool to Promote Patient-Centered Care in Pediatric Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
23(5): 813-819, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28132870
12.
Advances in understanding the pathogenesis of graft-versus-host disease.
Br J Haematol;
173(2): 190-205, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27019012
13.
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant;
59(3): 373-379, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38177221
14.
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome.
Leuk Res Rep;
17: 100329, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35651540
15.
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy.
Leuk Res;
132: 107348, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423073
16.
Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes.
JCO Clin Cancer Inform;
2: 1-12, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30652535
17.
Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia.
Leuk Res;
123: 106984, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401944
18.
Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies.
Clin Lymphoma Myeloma Leuk;
22(7): e495-e497, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35148976
19.
Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients.
Cancer Cell;
40(4): 340-342, 2022 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35202585
20.
Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885].
Transplant Cell Ther;
28(10): 717, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36202527